Growth Metrics

Lexicon Pharmaceuticals (LXRX) Operating Expenses: 2009-2011

Historic Operating Expenses for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $115.9 million.

  • Lexicon Pharmaceuticals' Operating Expenses rose 42.26% to $33.7 million in Q4 2011 from the same period last year, while for Dec 2011 it was $115.9 million, marking a year-over-year increase of 15.22%. This contributed to the annual value of $115.9 million for FY2011, which is 15.22% up from last year.
  • According to the latest figures from FY2011, Lexicon Pharmaceuticals' Operating Expenses is $115.9 million, which was up 15.22% from $100.6 million recorded in FY2010.
  • Lexicon Pharmaceuticals' 5-year Operating Expenses high stood at $115.9 million for FY2011, and its period low was $100.6 million during FY2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Operating Expenses value was $100.7 million (recorded in 2009), while the average stood at $105.7 million.
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Operating Expenses decreased by 0.03% in 2010, and later rose by 15.22% in 2011.
  • Lexicon Pharmaceuticals' Operating Expenses (Yearly) stood at $100.7 million in 2009, then fell by 0.03% to $100.6 million in 2010, then grew by 15.22% to $115.9 million in 2011.